Showing results (41-50 of 237) with videos related to
Sort By:
Pageof 24
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 22, 2004
[Successful treatment of acute myelomonocytic leukemia developed from essential thrombocythemia with cytarabine plus etoposide]Yuko Ishii, Akihiko Goto, Tomoko Katagiri, et al.Oncotarget|July 21, 2016
Combination therapy with copanlisib and ABL tyrosine kinase inhibitors against Philadelphia chromosome-positive resistant cellsSeiichi Okabe, Tetsuzo Tauchi, Yuko Tanaka, et al.Journal of Hematology & Oncology|April 30, 2014
Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cellsSeiichi Okabe, Tetsuzo Tauchi, Seiichiro Katagiri, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|June 1, 2004
[A case of eosinophilic pneumonia possibly associated with 5-aminosalicylic acid (5-ASA)]Yusuke Hakoda, Masahiro Aoshima, Masao Kinoshita, et al.Cancer Science|April 24, 2008
Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL: in vitro and in vivo studiesDaigo Akahane, Tetsuzo Tauchi, Seiichi Okabe, et al.Molecular Cancer Therapeutics|March 27, 2003
Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cellsAkihiro Nakajima, Tetsuzo Tauchi, Masahiko Sumi, et al.Cancer Genetics and Cytogenetics|August 1, 2006
Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomalyYi-Chang Liu, Keisuke Miyazawa, Goro Sashida, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 31, 2006
[Successful treatment with interferon-alpha in a case of acute myeloid leukemia with del (20q) following polycythemia vera]Masahiko Sumi, Tetsuzo Tauchi, Tomoiku Takaku, et al.Immunity & Ageing : I & A|November 16, 2011
Age-related decrease of miRNA-92a levels in human CD8+ T-cells correlates with a reduction of naïve T lymphocytesMichiyo Ohyashiki, Junko H Ohyashiki, Ayako Hirota, et al.Advances and Applications in Bioinformatics and Chemistry : AABC|September 16, 2011
A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cellsJunko H Ohyashiki, Ryoko Hamamura, Chiaki Kobayashi, et al.Pageof 24